ReFacto®1 and Advate®2: A single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia A

Jorge Di Paola, M. P. Smith, R. Klamroth, P. M. Mannucci, C. Kollmer, J. Feingold, C. Kessler, H. Pollmann, M. Morfini, C. Udata, C. Rothschild, C. Hermans, R. Janco

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint Dive into the research topics of 'ReFacto®<sup>1</sup> and Advate®<sup>2</sup>: A single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia A'. Together they form a unique fingerprint.

Medicine & Life Sciences